⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Enlivex Therapeutics Ltd. Ordinary Shares

$0.9404
-0.0546 (-5.49%)

Volume:

223.424K ($212.23K)

Market Capitalization:

$16.44M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Enlivex Therapeutics Market Segments

After Hours

-0.0191(-1.99%)
Open$0.9595
Close$0.9404
Low$0.9308
Low Change-0.0287 (-2.99%)
High$0.9786
High Change+0.0191 (+1.99%)
Range$0.0478
Volume6.242K
Dollar Volume$5.87K

Regular Trading Hours

-0.0500(-5.00%)
Open$1.0000
Close$0.9500
Low$0.9500
Low Change-0.0500 (-5.00%)
High$1.0700
High Change+0.0700 (+7.00%)
Range$0.1200
Volume216.495K
Dollar Volume$205.67K

Premarket

+0.0189(+1.93%)
Open$0.9811
Close$1.0000
Low$0.9808
Low Change-0.0003 (-0.03%)
High$1.0400
High Change+0.0589 (+6.00%)
Range$0.0592
Volume687
Dollar Volume$687.00

Overnight

*No Trades in Segment

After Hours Yesterday

+0.0993(+10.13%)
Open$0.9807
Close$1.0800
Low$0.9807
Low Change0.0000 (0.00%)
High$1.0800
High Change+0.0993 (+10.13%)
Range$0.0993
Volume4.226K
Dollar Volume$4.56K

Regular Trading Hours Yesterday

-0.0350(-3.40%)
Open$1.0300
Close$0.9950
Low$0.9798
Low Change-0.0502 (-4.87%)
High$1.0600
High Change+0.0300 (+2.91%)
Range$0.0802
Volume264.792K
Dollar Volume$263.47K

Premarket Yesterday

-0.1048(-9.08%)
Open$1.1545
Close$1.0497
Low$1.0300
Low Change-0.1245 (-10.78%)
High$1.1545
High Change+0.0000 (+0.00%)
Range$0.1245
Volume5.866K
Dollar Volume$6.16K

Enlivex Therapeutics News

There is no current news for this stock at the moment.

Enlivex Therapeutics Top Trades

Enlivex Therapeutics's top trade so far today returned +9.09%, while the top short trade returned -13.01%.

Enlivex Therapeutics Moving Averages

5 Day Moving Average (SMA5)$1.0800
10 Day Moving Average (SMA10)$1.2055
20 Day Moving Average (SMA20)$1.3838
50 Day Moving Average (SMA50)$2.4744
100 Day Moving Average (SMA100)$1.6095
200 Day Moving Average (SMA200)$1.3051

Enlivex Therapeutics Statistics

Average Volume (30 Days)294.58K
P/E Ratio (Current)-2.17
EPS (Current)-$0.48
Dividend Yield0.00%
Free Cash Flow
Cash Ratio1.30
Current Ratio8.72
Quick Ratio8.72
Debt to Equity0.00
Enterprise Value$12.51M
EV to EBITDA-1.21
EV to Sales
Price to Book0.51
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets-0.21%
Return on Equity-0.24%

Enlivex Therapeutics Stock Splits

There have been 3 stock splits for Enlivex Therapeutics (ENLV). The last reverse stock split occured on July 9, 2026 and reduced the outstanding shares at a ratio of 15:1.

DateTypeRatio
Jul 9, 2026Reverse15:1
Mar 6, 2019Reverse8:1
Sep 25, 2017Reverse5:1

Enlivex Therapeutics Dividends

There have been no dividends for Enlivex Therapeutics (ENLV).